Kaleido Biosciences (KLDO) Competitors $0.0005 0.00 (0.00%) As of 10/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock KLDO vs. BLBX, ABTS, STIX, ZSPC, XTKG, MNDO, BNAI, MTC, NTCL, and RMSGShould you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Blackboxstocks (BLBX), Abits Group (ABTS), Semantix (STIX), zSpace (ZSPC), X3 (XTKG), MIND C.T.I. (MNDO), Brand Engagement Network (BNAI), MMTec (MTC), NetClass Technology (NTCL), and Real Messenger (RMSG). These companies are all part of the "computer software" industry. Kaleido Biosciences vs. Its Competitors Blackboxstocks Abits Group Semantix zSpace X3 MIND C.T.I. Brand Engagement Network MMTec NetClass Technology Real Messenger Blackboxstocks (NASDAQ:BLBX) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment. Does the media refer more to BLBX or KLDO? In the previous week, Blackboxstocks had 4 more articles in the media than Kaleido Biosciences. MarketBeat recorded 4 mentions for Blackboxstocks and 0 mentions for Kaleido Biosciences. Blackboxstocks' average media sentiment score of 0.49 beat Kaleido Biosciences' score of 0.00 indicating that Blackboxstocks is being referred to more favorably in the media. Company Overall Sentiment Blackboxstocks Neutral Kaleido Biosciences Neutral Which has more risk and volatility, BLBX or KLDO? Blackboxstocks has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Do analysts recommend BLBX or KLDO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Blackboxstocks 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Kaleido Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BLBX or KLDO more profitable? Kaleido Biosciences has a net margin of 0.00% compared to Blackboxstocks' net margin of -163.66%. Kaleido Biosciences' return on equity of 0.00% beat Blackboxstocks' return on equity.Company Net Margins Return on Equity Return on Assets Blackboxstocks-163.66% -76.91% -38.31% Kaleido Biosciences N/A N/A N/A Do institutionals and insiders have more ownership in BLBX or KLDO? 3.6% of Blackboxstocks shares are owned by institutional investors. Comparatively, 81.6% of Kaleido Biosciences shares are owned by institutional investors. 28.3% of Blackboxstocks shares are owned by company insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has stronger valuation and earnings, BLBX or KLDO? Blackboxstocks has higher revenue and earnings than Kaleido Biosciences. Blackboxstocks is trading at a lower price-to-earnings ratio than Kaleido Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlackboxstocks$2.34M17.32-$3.47M-$1.07-9.99Kaleido Biosciences$1.10M0.02-$95.48M-$2.240.00 SummaryBlackboxstocks beats Kaleido Biosciences on 9 of the 14 factors compared between the two stocks. Get Kaleido Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLDO vs. The Competition Export to ExcelMetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$21K$224.24M$6.09B$10.55BDividend YieldN/A3.81%5.73%4.78%P/E Ratio0.0099.5085.0827.19Price / Sales0.025,898.48604.99132.96Price / CashN/A13.1937.8662.13Price / BookN/A99.1912.396.65Net Income-$95.48M-$90.99M$3.32B$276.79M7 Day PerformanceN/A0.72%2.31%1.75%1 Month PerformanceN/A6.09%9.69%5.15%1 Year PerformanceN/A692.24%73.82%36.96% Kaleido Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLDOKaleido Biosciences0.1682 of 5 stars$0.00flatN/AN/A$21K$1.10M0.0080BLBXBlackboxstocks1.1415 of 5 stars$6.79+6.8%N/A+281.8%$24.10M$2.34M-6.3540Earnings ReportShort Interest ↓ABTSAbits Group0.2484 of 5 stars$10.00-1.2%N/A-10.2%$23.98M$6.71M0.0020STIXSemantixN/AN/AN/AN/A$23.73M$264.23M0.004ZSPCzSpace3.7785 of 5 stars$1.01+2.9%$10.00+890.1%N/A$23.60M$38.10M0.0070Short Interest ↑XTKGX31.5785 of 5 stars$1.55-7.7%N/A-54.9%$23.05M$11.61M0.00200Positive NewsMNDOMIND C.T.I.2.4866 of 5 stars$1.10-0.9%N/A-45.2%$22.61M$21.45M7.86160High Trading VolumeBNAIBrand Engagement Network0.9752 of 5 stars$0.69+37.1%N/A-56.3%$21.67M$100K-0.8026News CoveragePositive NewsEarnings ReportShort Interest ↑High Trading VolumeMTCMMTec1.2825 of 5 stars$0.85-1.0%N/A-70.8%$21.64M$1.87M0.0060Analyst ForecastShort Interest ↓NTCLNetClass TechnologyN/A$1.42+5.2%N/AN/A$21.01M$10.10M0.0031News CoverageShort Interest ↓Gap UpRMSGReal Messenger1.288 of 5 stars$2.08-5.5%N/AN/A$19.52MN/A0.00N/APositive NewsShort Interest ↓ Related Companies and Tools Related Companies Blackboxstocks Competitors Abits Group Competitors Semantix Competitors zSpace Competitors X3 Competitors MIND C.T.I. Competitors Brand Engagement Network Competitors MMTec Competitors NetClass Technology Competitors Real Messenger Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLDO) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kaleido Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kaleido Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
